• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    65.33 Down 0.98(1.48%) Apr 17, 4:00PM EDT
    |After Hours : 65.45 Up 0.12 (0.18%) Apr 17, 7:41PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 84,861   44,063   57,076   28,161  
    Cost of Revenue -   -   -   -  
    Gross Profit 84,861   44,063   57,076   28,161  
    Operating Expenses
    Research Development67,953  61,086  59,264  53,448  
    Selling General and Administrative6,827  4,471  4,462  4,380  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 10,081   (21,494) (6,650) (29,667)
    Income from Continuing Operations
    Total Other Income/Expenses Net12,870  1,213  411  1,054  
    Earnings Before Interest And Taxes22,951  (20,281)(6,239)(28,613)
    Interest Expense7,307  4,998  4,961  4,943  
    Income Before Tax15,644  (25,279)(11,200)(33,556)
    Income Tax Expense(15,409)1,397  881  (2,276)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops22,761  (26,676)(12,081)(31,280)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 31,053   (26,676) (12,081) (31,280)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 31,053   (26,676) (12,081) (31,280)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.